Resources

Type of publications
Regions
Diseases
5037 results found
2025 ∙ Abaate, T. J. Buowari, D. Y. Agiri, U. A. Inimgba, T. Ogbonna, V. I. Onyeaghala, C. Worgu, G. O. Somiari, A. Ezebuiro, E. I. Onuah, I. A.
Prevalence of COVID-19 Vaccine Hesitancy Among Healthcare Workers in Nigeria: A Systematic Review and Meta-Analysis
Africa Nigeria Healthcare workers COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Sardinha, D. M. Silva, M. J. A. Bispo, S. K. S. da Silva, A. P. O. Lima, K. V. B. Ferreira, I. P. Lima, Lngc
Prevalence of COVID-19 vaccine hesitancy in Brazil: a systematic review and meta-analysis
Americas All age groups Parents/caregivers COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Tamuzi, J. L. Katoto, Pdmc Ndwandwe, D. E. Wiysonge, C. S. Nyasulu, P. S.
Prevalence of missed opportunities for vaccination (MOV) indicators among children aged 12-23 months in sub-Saharan African countries: An individual-level meta-analysis of DHS and MICS national household data surveys
Africa Children Coverage Administration
Rating:
Not applicable
2025 ∙ Yappalparvi, A. Gaidhane, S. Padmapriya, G. Kaur, I. Lal, M. Iqbal, S. Prasad, G. V. S. Pramanik, A. Sharma, P. Malik, P. Vishwakarma, T. Punia, A. Jagga, M. Mehta, R. Sah, S. Shabil, M. Satapathy, P. Bushi, G. Parsa, A. D. Kabir, R.
Prevalence of Mpox Vaccine Acceptance Among Students: A Systematic Review and Meta-Analysis
Adolescents Adults Mpox Acceptance
Rating:
Not applicable
2025 ∙ Yappalparvi, A. Khatib, M. N. Balaraman, A. K. Rekha, M. M. Kaur, M. Sharma, G. C. Sudan, P. Naidu, K. S. Singh, R. Ramashankar, S. Khati, K. Chauhan, S. S. Verma, L. Sidhu, A. Mehta, R. Sah, R. Gaidhane, A. M. Shabil, M. Chipeta, J. C. Bushi, G.
Prevalence of Mpox vaccine acceptance and hesitancy among people living with HIV: a comprehensive systematic review and meta-analysis
All age groups Mpox Acceptance
Rating:
Not applicable
2025 ∙ do Nascimento, G. R. da Silva Santos, A. C. Silva, N. N. T. Guilmaraes, N. S. Lima, A. A. Coura-Vital, W.
Prevalence of non-vaccine high-risk HPV cervical infections in vaccinated women: a systematic review and meta-analysis
Adolescents Adults Human papillomavirus (HPV) Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Xu, H. Tiffany, A. Luquero, F. J. Kanungo, S. Bwire, G. Qadri, F. Garone, D. Ivers, L. C. Lee, E. C. Malembaka, E. B. Mendiboure, V. Bouhenia, M. Breakwell, L. Azman, A. S.
Protection from killed whole-cell cholera vaccines: a systematic review and meta-analysis
All age groups Cholera Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Ekhator, E. Essien, V. G. Afolabi, O. E. Okundaye, M. I. Adewonbi, T.
Public awareness and acceptance of malaria vaccine in Sub-Saharan Africa: a systematic review
Africa Parents/caregivers Malaria Acceptance
Rating:
Not applicable
2025 ∙ Stuurman, A. L. Enxing, J. Gutierrez, A. V. Gray, C. M. Sepulveda-Pachon, I. T. Ubamadu, E. Bandell, A. Taylor, S. El Azzi, G. Meeraus, W.
Real-world effectiveness of live attenuated influenza vaccines (LAIV) and inactivated influenza vaccines (IIV) in children from 2003 to 2023: a systematic literature review and network meta-analysis
Newborn Children Adolescents Adults Influenza Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Trusinska, D. Lee, B. Ferdous, S. Kwok, H. H. Y. Gordon, B. Gao, J. Ma, L. Xiong, H. Sheikh, S. A. Schwarze, J. Busby, J. Gibbons, C. Drysdale, S. B. Ritchie, S. L. Williams, T. Shi, T.
Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysis
Newborn Children Adults Older adults Pregnant women RSV (Respiratory syncytial virus) Coverage
Rating:
Not applicable
Loading...